An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer-Reference-Cited by-同舟云学术

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer

Published:2021-08-20 Issue:5 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Vrouwe Josephina P. M.¹²^ORCID,Kamerling Ingrid M. C.¹³^ORCID,Esdonk Michiel J.¹^ORCID,Metselaar Josbert M.⁴⁵^ORCID,Stuurman Frederik E.¹⁶^ORCID,Pluijm Gabri⁷^ORCID,Burggraaf Jacobus¹⁸^ORCID,Osanto Susanne²^ORCID

Affiliation:

1. Centre for Human Drug Research Leiden The Netherlands

2. Department of Medical Oncology Leiden University Medical Centre Leiden The Netherlands

3. Department of Infectious Diseases Leiden University Medical Centre Leiden The Netherlands

4. Enceladus Pharmaceuticals Naarden The Netherlands

5. Rheinisch‐Westfälische Technische Hochschule Aachen University Clinic Aachen Germany

6. Department of Clinical Pharmacology and Toxicology Leiden University Medical Centre Leiden The Netherlands

7. Department of Urology Leiden University Medical Centre Leiden The Netherlands

8. Leiden Academic Centre for Drug Research Leiden The Netherlands

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.845

Reference43 articles.

1. Cancer statistics, 2020

2. Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients

3. A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer

4. Bone Health in Men with Prostate Cancer: Review Article

5. Flutamide Versus Prednisone in Patients With Prostate Cancer Symptomatically Progressing After Androgen-Ablative Therapy: A Phase III Study of the European Organization for Research and Treatment of Cancer Genitourinary Group

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of nanocarriers for treatment of urologic cancers;Urologic Oncology: Seminars and Original Investigations;2023-12

2. A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma;Drug Delivery and Translational Research;2023-01-02